Session Details

Cholesterol-lowering therapy for primary and secondary prevention
29 Aug 16:30 - 18:00 Prevention - Lipids Advances in Science, Mobile App - Ask a Question Chisinau - Village 4
Chairpersons: Louise BOWMAN (Oxford, United Kingdom), Robert G XUEREB (Ta' Xbiex, Malta)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
16:315965State of the Art: cholesterol-lowering therapy for primary and secondary prevention Jennifer ROBINSON (Iowa City, United States of America)
16:485966Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes mellitus: a systematic review and meta-analysis with over 10,000 patientsLuiz Sergio CARVALHO (Brasilia, Brazil)
17:065967Effect of the magnitude of LDL lowering on the incidence of cataract among patients treated with statins or PCSK9 antibodiesJohn B KOSTIS (New Brunswick, United States of America)
17:245968Comparison of the low-density lipoprotein cholesterol target value and the preventive effect of statins in elderly patients and younger patientsAkihiro ENDO (Izumo, Japan)
17:425969Lipid-lowering therapy in primary prevention: where will we be 10 years from nowAlberico CATAPANO (Milan, Italy)